Quick Comparison

EGF (Epidermal Growth Factor)Retinol
Typical ConcentrationConcentrations vary by product (typically measured in ppm or sh-oligopeptide-1 percentage). Applied once or twice daily. Best used after procedures or on aging skin. Apply before oils/occlusives. Store in refrigerator for stability.Concentrations: 0.025%-1%. Begin with 0.25-0.5% 2-3 times per week. Increase frequency over 4-8 weeks. 1% retinol is roughly equivalent to 0.025% tretinoin in efficacy. Apply at night after cleansing. Encapsulated/stabilized forms (retinol in liposomes) are less irritating.
ApplicationTopical (serum, cream, ampoule). Apply to clean skin. Temperature-sensitive — some products require refrigeration.Topical (serum, cream, oil). Apply at night. Look for products in opaque, airless pump packaging — retinol degrades rapidly with air and light exposure.
Research Papers10 papers10 papers
Categories

Mechanism of Action

EGF (Epidermal Growth Factor)

EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.

Retinol

Retinol undergoes two-step enzymatic conversion in keratinocytes: alcohol dehydrogenase (ADH) and retinol dehydrogenase (RDH) oxidize retinol to retinaldehyde; retinaldehyde dehydrogenase (RALDH) then oxidizes it to all-trans retinoic acid. Conversion is rate-limited by enzyme availability and CRBP expression, delivering retinoic acid gradually—explaining retinol's gentler profile. Only retinoic acid binds RAR/RXR receptors. Once converted, it activates identical pathways as tretinoin: upregulating keratinocyte proliferation, stimulating fibroblast collagen I/III via TGF-beta, inhibiting MMPs, and normalizing melanocyte activity. Multi-step metabolism creates tissue-specific conversion favoring epidermal effects. Identical downstream effects to tretinoin with reduced irritation.

Risks & Safety

EGF (Epidermal Growth Factor)

Common

Very well-tolerated.

Serious

Theoretical concern about promoting growth of pre-existing skin cancers (unproven but debated).

Rare

Mild irritation.

Retinol

Common

Dryness, flaking, mild redness, sun sensitivity (use SPF daily). Less severe than tretinoin.

Serious

Avoid during pregnancy (precautionary — less evidence than tretinoin but same class).

Rare

Contact dermatitis in sensitive individuals.

Full Profiles